Overview

Novel ROS-scavenging Nanoenzymes for the Treatment of Radiation Dermatitis in Patients With Head and Neck Cancer

Status:
RECRUITING
Trial end date:
2025-10-15
Target enrollment:
Participant gender:
Summary
There is no standard treatment for radiation dermatitis. In this study, the investigators have designed novel ROS-scavenging nanoenzymes and aim to evaluate their effectiveness in preventing radiation dermatitis in patients with head and neck cancer.
Phase:
NA
Details
Lead Sponsor:
West China Hospital
Treatments:
Standard of Care